ArticlePLoS biology2025
Sublethal executioner caspase activation in hepatocytes promotes liver regeneration through the JAK/STAT3 pathway.
Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evasion of cell death despite mitochondrial outer membrane permeabilization: an oncogenic outcome of apoptosis.Apoptosis : an international journal on programmed cell death · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Apoptosis has been reported to drive regeneration in many species. Executioner caspases, the key effectors in apoptosis, are responsible for production and secretion of various pro-regenerative signals from apoptotic cells to the surrounding cells. However, whether executioner caspase activation (ECA) can promote regeneration without inducing apoptosis is poorly understood. Here, by generating transgenic mice carrying a lineage tracing system for cells that have experienced ECA, we demonstrate that ECA occurs in a few hepatocytes in homeostatic livers. The fraction of hepatocytes with ECA dramatically expands during regeneration after partial hepatectomy (PHx) or carbon tetrachloride (CCl4) treatment. Interestingly, rather than undergoing apoptosis, the majority of hepatocytes with ECA survive and proliferate during liver regeneration. Inhibition of ECA in livers results in reduced hepatocyte proliferation and impaired regeneration, whereas increasing ECA to a level sufficient to kill hepatocytes also impedes regeneration, suggesting that ECA needs to be precisely controlled at a sublethal level. Mechanistically, we show that ECA promotes hepatocyte proliferation through enhancing JAK/STAT3 activity. Our work reveals an essential apoptosis-independent role of executioner caspases in liver regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.